Viewpoint: Mismatch Between the European and American Guidelines on Oral Antiplatelet P2Y12 Inhibitors After Acute Coronary Syndromes

Thrombosis and Haemostasis - Germany
doi 10.1160/th13-02-0142
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Systematic Reviews: Causes of Non-Adherence to P2Y12 Inhibitors in Acute Coronary Syndromes and Response to Intervention

Open Heart
Cardiovascular MedicineCardiology
2016English

Pcv24 - Safety and Effectiveness of Contemporary P2y12 Inhibitors in East Asian Patients With Acute Coronary Syndromes: A Nationwide Population-Based Cohort Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Acute Coronary Syndromes

British Medical Journal
Medicine
2015English

Acute Coronary Syndromes

2018English

Acute Coronary Syndromes

JAMA - Journal of the American Medical Association
Medicine
2008English

Acute Coronary Syndromes

2007English

Acute Coronary Syndromes

2006English

Antiplatelet Therapy in Acute Coronary Syndrome

Continuing Cardiology Education
2017English

Prognosis of Acute Coronary Syndromes After Radiotherapy for Breast Cancer

Radiotherapy and Oncology
Nuclear MedicineOncologyRadiologyHematologyImaging
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy